Article
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
4 Feb 2011
Abstract excerpt
Rifaximin is a rifampicin derivative, poorly absorbed by the gastro-intestinal tract. We studied the in vitro susceptibility to rifamixin of 1082 Clostridium difficile isolates; among these, 184 isolates from a strain collection were tested by an in-house rifaximin disc (40 µg) diffusion test, by an in-house rifaximin broth microdilution test, by rifampicin Etest and by rpoB gene sequencing. In the absence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
